NeuroDefend, a novel traditional Chinese medicine, attenuates amyloid-β and tau pathology in experimental Alzheimer's disease models

Published on Oct 1, 2019in Journal of Food and Drug Analysis4.18
· DOI :10.1016/j.jfda.2019.09.004
Ashok Iyaswamy3
Estimated H-index: 3
(Hong Kong Baptist University),
Senthil Kumar Krishnamoorthi1
Estimated H-index: 1
(Hong Kong Baptist University)
+ 12 AuthorsMin Li27
Estimated H-index: 27
(Hong Kong Baptist University)
Abstract Alzheimer's disease (AD) is the most common age-related neurodegenerative disorder. Amyloid-β (Aβ) and hyper-phosphorylated tau accumulation are accountable for the progressive neuronal loss and cognitive impairments usually observed in AD. Currently, medications for AD offer moderate symptomatic relief but fail to cure the disease; hence development of effective and safe drugs is urgently needed for AD treatment. In this study, we investigated a Chinese medicine (CM) formulation named NeuroDefend (ND), for reducing amyloid β (Aβ) and tau pathology in transgenic AD mice models. Regular oral administration of ND improved cognitive function and memory in 3XTg-AD and 5XFAD mice. In addition, ND reduced beta-amyloid precursor protein (APP), APP C-terminal fragments (CTF-β/α), Aβ and 4G8 positive Aβ burden in 3XTg-AD and 5XFAD mice. Furthermore, ND efficiently reduced the levels of insoluble phospho-tau protein aggregates and AT8 positive phospho tau neuron load in 3XTg-AD mice. Hence, ND could be a promising candidate for the treatment of AD in humans.
  • References (24)
  • Citations (0)
#1Rui-Yuan Pan (CAS: Chinese Academy of Sciences)H-Index: 1
#2Jun MaH-Index: 4
Last.Zengqiang YuanH-Index: 19
view all 12 authors...
1 CitationsSource
#1Siva Sundara Kumar Durairajan (Hong Kong Baptist University)H-Index: 15
#2Ashok Iyaswamy (Hong Kong Baptist University)H-Index: 3
Last.Min Li (Hong Kong Baptist University)H-Index: 5
view all 13 authors...
3 CitationsSource
6 CitationsSource
7 CitationsSource
#1Dennis J. Selkoe (Brigham and Women's Hospital)H-Index: 162
#2John Hardy (UCL Institute of Neurology)H-Index: 152
1,165 CitationsSource
#1Xiu-Zhen Zhang (SDUT: Shandong University of Technology)H-Index: 1
#2Shao-Song Qian (SDUT: Shandong University of Technology)H-Index: 1
Last.Rui-Qi Wang (SDUT: Shandong University of Technology)H-Index: 1
view all 4 authors...
32 CitationsSource
#1Natura MyekuH-Index: 3
Last.Karen DuffH-Index: 79
view all 7 authors...
145 CitationsSource
#1Qing-Fei Zhao (Qingdao University)H-Index: 6
#2Lan Tan (Ocean University of China)H-Index: 48
Last.Jin-Tai YuH-Index: 48
view all 11 authors...
126 CitationsSource
#1Min Liu (Southern Medical University)H-Index: 1
#2Haibiao Guo (Southern Medical University)H-Index: 8
Last.Ren-an QinH-Index: 1
view all 8 authors...
9 CitationsSource
#1Woo-Hyun Cho (Konkuk University)H-Index: 4
#2Jung-Cheol Park (Konkuk University)H-Index: 3
Last.Jung-Soo Han (Konkuk University)H-Index: 20
view all 5 authors...
8 CitationsSource
Cited By0
View next paperAnalyses of the Link Between Amyloid and Tau Pathology in an AD Mouse Model (3xtg-AD): Disease Progression with Increased Levels of Abeta and Tau Peptides